Foster City, CA, United States of America

Xiang Xu

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 63(Granted Patents)


Location History:

  • San Francisco, CA (US) (2003)
  • S. San Francisco, CA (US) (2004)
  • South San Francisco, CA (US) (2003 - 2014)
  • Foster City, CA (US) (2012 - 2021)

Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Xiang Xu and His Contributions to Pharmaceutical Science

Introduction

Xiang Xu, based in Foster City, CA, is a prominent inventor in the field of pharmaceutical sciences with an impressive portfolio of 28 patents. His innovative work primarily focuses on the activation of AMPK pathways, contributing to the development of potential treatments for various medical conditions.

Latest Patents

Two of Xiang Xu's latest patents showcase his groundbreaking research. The first patent, titled "Direct AMPK Activators," discloses benzimidazole compounds along with pharmaceutical compositions and methods of use. One embodiment of this patent describes a compound structure capable of activating the AMPK pathway, which can be instrumental in the treatment of diseases linked to metabolic functions.

The second patent, "Carboxamide Compounds and Methods for Using the Same," introduces carboxamide compounds and their applications in pharmaceutical compositions. Similar to his previous work, this invention focuses on compounds that activate the AMPK pathway, providing promising avenues for addressing metabolism-related disorders and conditions.

Career Highlights

Throughout his career, Xiang Xu has made significant strides in the pharmaceutical industry. He has worked for Rigel Pharmaceuticals, where he further refined his expertise in drug development and innovation. His extensive background and commitment to research underscore his reputation as a thought leader in the field.

Collaborations

Xiang Xu collaborates closely with fellow innovators and researchers, including Rajinder Paul Singh and Hui Hong. These partnerships enhance the collective knowledge and drive forward the pursuit of innovative solutions within pharmaceutical sciences.

Conclusion

In summary, Xiang Xu stands out as a pivotal figure in the realm of pharmaceutical innovation, with a strong portfolio of patents that enhance our understanding of metabolic pathways and potential therapies. His dedication to developing compounds that activate the AMPK pathway positions him at the forefront of medical research, paving the way for future breakthroughs in treating metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…